Challenges

IIPM PUBLICATION

As players in an emerging biotech market, Spanish companies still have some challenges ahead. The first and most significant one, many observers say, is access to financial resources. Spanish investors are only now beginning to understand the potential of biotechnology and make a long-term commitment. And those same Spanish investors are crucial in getting companies to a place where they will be attractive to international investors.

That’s the position Cellerix, the Genetrix spinoff, has already reached. Genetrix is working on finding partners in Europe, Japan, and the United States. “When you turn to outside venture capitalists, they always want to have a Spanish local investor who takes the lead, and that’s been difficult in the past,” says Claudia Jimenez.

For Complete IIPM Article, Click on IIPM Article

Source : IIPM Editorial, 2007

An IIPM and Professor Arindam Chaudhuri (Renowned Management Guru and Economist) Initiative

For More IIPM Article, Visit Below....
http://iipm-top-mba-institute.spaces.live.com/
http://iipm-here-is-your-future.spaces.live.com/
http://iipm-campus-events.spaces.live.com/
http://iipm-institute.spaces.live.com/